OMDA

시간 외 거래: 19.02

Omada Health Inc (OMDA)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Omada Health Inc Stock (OMDA) Company Profile

Omada Health Inc

Healthcare (1163)

888-987-8337

500 SANSOME STREET, SAN FRANCISCO

최신 SEC 제출 서류

OMDA's Discussions on Twitter

OMDA을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
OMDA Omada Health Inc	19.02	1.11B	0	0	0	0.00
VEEV Veeva Systems Inc	282.13	46.19B	2.86B	780.66M	1.20B	4.72
TEM Tempus Ai Inc	60.87	9.61B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	66.58	10.89B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	93.05	7.86B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	34.59	5.92B	906.14M	-52.62M	89.62M	-0.3621

Omada Health Inc Stock (OMDA) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-07-01	개시	Barclays	Overweight
2025-07-01	개시	Canaccord Genuity	Buy
2025-07-01	개시	Evercore ISI	Outperform
2025-07-01	개시	Goldman	Buy
2025-07-01	개시	JP Morgan	Overweight
2025-07-01	개시	Morgan Stanley	Overweight
2025-07-01	개시	Needham	Buy

Omada Health Inc 주식(OMDA)의 최신 뉴스

Omada Health Inc (OMDA) 재무 분석

Omada Health Inc (OMDA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

Omada Health Inc (OMDA)

Omada Health Inc Stock (OMDA) Company Profile

OMDA을(를) 다른 주식과 비교

Omada Health Inc Stock (OMDA) Upgrades & Downgrades

Omada Health Inc 주식(OMDA)의 최신 뉴스

Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest

Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget

Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa

Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com India

Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India

Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa

Omada Health price target raised to $28 from $27 at Canaccord - TipRanks

Omada Health price target raised to $24 from $21 at Barclays - TipRanks

Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks

Omada Health Reports Strong Q2 2025 Growth - TipRanks

Omada Health reports Q2 EPS (24c), consensus (13c) - TipRanks

Omada Health beats on revenue in first earnings report since IPO - CNBC

Omada Health Reports Second Quarter 2025 Results - The Manila Times

Earnings Flash (OMDA) Omada Health, Inc. Reports Q2 Revenue $61.4M, vs. FactSet Est of $55.3M - MarketScreener

U.S. Digital Therapeutics Market to Witness Remarkable Growth - openPR.com

Omada Health, Inc. (NASDAQ:OMDA) Receives $23.86 Average PT from Analysts - Defense World

Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook - TipRanks

Health Coach Market is evolving rapidly Through 2025 To 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com

Digital Therapeutics for Diabetes Market is projected to reach - openPR.com

Omada Health: A Buy Rating for a Company with Strong Distribution Partnerships and Clinical Validation - AInvest

Omada Health: Long Growth Runway Ahead - Seeking Alpha

Omada Health Sets Q2 Earnings Date: Virtual Healthcare Leader Reports August 7 - Stock Titan

Interleukin Inhibitors Market Generated Opportunities, Future Scope by 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com

Omada Health, Inc.: A Promising Buy Amid Technical Weakness and Growth Potential - TipRanks

IPO market remains 'sluggish' despite recent San Francisco listings - The Business Journals

EQBK issues 1.73M shares, completes NBC merger & adds new director | OMDA SEC FilingForm 4 - Stock Titan

More than $16B in med-tech funding raised through 1H25 - BioWorld MedTech

The Making of Omada Health | Omada Health Co-Founder & CEO Sean Duffy - iHeart

These are the 9 healthcare startups next in line to go public, according to bankers and investors - Business Insider

Omada Health IPO signals healthier market, avoids ‘down-round’ trend - MSN

Health Coach Market Set to Witness Significant Growth by 2025-2032 | Noom, Inc., HealthifyMe, Omada Health - newstrail.com

Omada Health Stock (OMDA): A Growth Story in Digital Health - Value The Markets

Omada Health stock initiated with Buy rating at Freedom Broker - Investing.com

Needham initiates coverage on Omada Health stock with Buy rating By Investing.com - Investing.com India

Omada Health initiated with a Buy at Needham - TipRanks

Omada Health initiated with an Overweight at JPMorgan - TipRanks

Omada Health initiated with an Overweight at Morgan Stanley - TipRanks

Omada Health initiated with an Overweight at Barclays - TipRanks

Don’t expect a wave of digital health IPOs quite yet - Modern Healthcare

Omada Health initiated with a Buy at Goldman Sachs - TipRanks

Omada Health: A Compelling Investment Opportunity in Digital Health with Strong Growth Potential - TipRanks

JPMorgan Issues Buy Rating for Omada Health, Inc. Citing Growth Potential in Underpenetrated $135 Billion Market and Strategic Partnerships - TipRanks

Omada Health: Strong Growth Prospects and Path to Profitability with Undervalued Potential - TipRanks

The long-awaited digital health IPO is back, but most late-stage healthcare startups aren't ready for it, according to bankers - Business Insider

Here are 12 Bay Area companies to watch for IPOs after Chime - The Business Journals

Omada Health prices IPO at $19 a share, raises $150M - MSN

Caris settles IPO at $21, trading starts at $28 - BioWorld MedTech

Health Coach Market Is Booming So Rapidly 2025-2032 -Noom, Inc., HealthifyMe, Omada Health, Inc., Iora Health - openPR.com

Omada Health releases new data on its GLP-1 companion program - Yahoo Finance

New Data: Omada Health GLP-1 Program Doubles Weight Loss Success vs Standard Care - Stock Titan

Digital Therapeutics Market: Opportunities in Mental Health - openPR.com

Omada Health Inc (OMDA) 재무 분석

매출

순이익

현금흐름

주당 순 이익

OMDA과 유사한 종목